Thaliglob 50mg Capsule
Prescription Required
Product introduction
Thaliglob 50mg Capsule is used in the treatment of multiple myeloma and lepra reaction. This medicine belongs to a group of medicines which affect how your immune system works.
Thaliglob 50mg Capsule is used in the treatment of many different blood and bone marrow diseases including some cancers.
Thaliglob 50mg Capsule is used in the treatment of many different blood and bone marrow diseases including some cancers.
Uses of Thaliglob Capsule
- Multiple myeloma
- Lepra reaction
Benefits of Thaliglob Capsule
In Multiple myeloma
If you have multiple myeloma, your body is destroying bone faster than it is being replaced. This makes bones weak and painful and more likely to break. Thaliglob 50mg Capsule may be prescribed along with other cancer treatments such as chemotherapy. It is an important part of your treatment and increases the survival rate of people with multiple myeloma. This medicine will kill the cancerous cells and prevent their further growth as well as spread to other parts of the body. Follow your doctor’s instructions carefully to get the most benefit. Supplements of calcium and Vitamin D3 are also effective and may be prescribed if you do not have high blood calcium levels.
In Lepra reaction
Lepra reactions are complicated inflammatory reactions that may occur before, during or after the treatment for leprosy, a serious bacterial skin disease. These reactions increase nerve damage and worsen disability in leprosy patients. Therefore lepra reactions need treatment with medicines such as Thaliglob 50mg Capsule in order to stimulate the immune system and aid in recovery. This medicine will also prevent further damage due to lepra reactions. Take it as prescribed by the doctor to get the most benefit.
Side effects of Thaliglob Capsule
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Thaliglob
- Nausea
- Rash
- Breathlessness
- Dizziness
- Edema (swelling)
- Decreased calcium level in blood
- Fatigue
- Muscle weakness
- Anxiety
- Confusion
- Decreased white blood cell count (neutrophils)
- Constipation
- Tremors
- Sensory neuropathy
- Change in body weight
- Decreased white blood cell count (lymphocytes)
- Thromboembolism
- Muscle pain
- Anaphylactic reaction
- Headache
- Sleepiness
- Decreased potassium level in blood
How to use Thaliglob Capsule
Take this medicine in the dose and duration as advised by your doctor. Thaliglob 50mg Capsule is to be taken empty stomach.
Safety advice
Alcohol
UNSAFE
Thaliglob 50mg Capsule may cause excessive drowsiness with alcohol.
Pregnancy
UNSAFE
Thaliglob 50mg Capsule is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Breast feeding
CONSULT YOUR DOCTOR
Thaliglob 50mg Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
UNSAFE
Thaliglob 50mg Capsule may cause side effects which could affect your ability to drive.
You may experience side effects, such as dizziness, tiredness, sleepiness or blurred vision with Thaliglob 50mg Capsule and this may affect your ability to drive.
You may experience side effects, such as dizziness, tiredness, sleepiness or blurred vision with Thaliglob 50mg Capsule and this may affect your ability to drive.
Kidney
SAFE IF PRESCRIBED
Thaliglob 50mg Capsule is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Thaliglob 50mg Capsule may not be needed in these patients. Please consult your doctor.
Liver
SAFE IF PRESCRIBED
Thaliglob 50mg Capsule is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Thaliglob 50mg Capsule may not be needed in these patients. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Thaliglob 50mg Capsule
₹32.0/Capsule
Thalix 50 Capsule
Fresenius Kabi India Pvt Ltd
₹39.62/capsule
35% costlier
Thaloda 50 Capsule
Alkem Laboratories Ltd
₹32.2/capsule
10% costlier
Thaangio 50mg Capsule
Dr Reddy's Laboratories Ltd
₹39.45/capsule
34% costlier
Redemide 50mg Capsule
Intas Pharmaceuticals Ltd
₹31.25/capsule
6% costlier
Thaloma 50mg Capsule
Sun Pharmaceutical Industries Ltd
₹22.5/capsule
23% cheaper
Quick tips
- Thaliglob 50mg Capsule should be taken on an empty stomach, try to take it at same time every day.
- Do not skip any dose and complete the course as suggested by your doctor.
- Use an effective method of birth control to avoid pregnancy while taking this medication.
- Do not donate blood during or after 7 days of the treatment with this medicine.
- Your doctor may get regular blood tests done to monitor your blood cell count and liver function.
Fact Box
Chemical Class
Phthalimides
Habit Forming
No
Therapeutic Class
ANTI INFECTIVES
Action Class
Thalidomide & its Immunomodulatory derivatives (IMiDs)
Patient concerns
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1740-42.
- Lake DF, Briggs AD, Akporiaye ET. Immunopharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 973-74.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1342-50.
Marketer details
Name: Globela Pharma Pvt Ltd
Address: 357, G.I.D.C. Road No.3,Sachin, Surat - 394 230 ,Gujarat, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹320
Inclusive of all taxes
10.0 capsules in 1 strip
SOLD OUT